News

  • Live Forever series: Dr Clint Phillips

    In the latest piece from our special  'Live Forever' series  we hear from Dr Clint Phillips, CEO and founder of Medici. Biohacking is a fun, trendy word however if you look at the root of its meaning, it’s not necessarily a term that I encourage people to idolize.  Hacking usually implies finding a secret back [...]

  • ‘Gamechanger’ Alzheimer’s drugs have ‘no meaningful’ effect, review finds

    So-called 'gamechanger' Alzheimer’s drugs made little noticeable difference for patients in trials, according to a review of anti-amyloid drugs. The analysis looked at trials involving people with mild cognitive impairment or mild dementia. It found the effects of anti-amyloid drugs on cognition and dementia severity over 18 months were “trivial”, while gains in functional ability [...]

  • Pancreatic cancer drug could double survival rates, study suggests

    A pancreatic cancer drug could double survival rates and cut the risk of death by more than a third, a trial suggests. Pancreatic cancer survival rates are among the lowest of all cancers, with only about 10 per cent of patients in Britain living longer than a year after diagnosis. Researchers at Northwestern University in [...]

  • Loneliness does not accelerate dementia, study suggests

    Loneliness may harm memory at first, but a major European study tracking more than 10,000 people over seven years suggests it does not speed dementia decline over time. Study participants who reported high levels of loneliness performed worse on memory tests at the start of the research period. However, their ability to recall information declined at [...]

  • Metabolic liver disease to affect almost 2bn by 2050

    Liver disease linked to obesity and high blood sugar could affect 1.8bn people worldwide by 2050, a study suggests. Metabolic dysfunction-associated steatotic liver disease, or MASLD, was previously known as non-alcoholic fatty liver disease. It is one of the most common and fastest-growing liver conditions worldwide. There are now 1.3bn people worldwide living with MASLD, [...]

  • Plant-rich diet linked to lower dementia risk, study finds

    A plant-rich diet may lower dementia risk, even when people start it in their late 50s or 60s, according to a new study. Older adults who cut many unhealthy foods from their diet over a decade had an 11 per cent lower risk of Alzheimer's and dementia than adults whose diets did not change, Lim [...]

  • AI tool predicts heart failure five years before it develops

    An AI tool predicted heart failure risk up to five years before onset with 86 per cent accuracy in 72,000 patients in England, researchers said. The AI tool, developed by a team at the University of Oxford, looks for signs in fat around the heart that show whether it is inflamed and unhealthy. Those signs [...]

  • Live forever report part three: Dr Cherry Lo

    Dr Cherry Lo, longevity advisor to supplement brand Manapura shares her thoughts with Agetech World in our on-going “Living Forever” series  "When Elon Musk speaks of 'reprogramming,' he is essentially identifying ageing as a solvable engineering issue. He believes we can overcome the fatal biological breakdowns by delivering biological 'OTA updates'. To understand why the ‘system’ eventually [...]

  • Daily Alzheimer’s pill slows brain shrinkage and improves cognition – study

    An Alzheimer's pill was linked to slower brain shrinkage and improved cognition over nearly three years in early disease, a new analysis suggests. The benefits seen in people with early Alzheimer's disease after a year of treatment with blarcamesine were sustained over nearly three years, according to new analysis from Anavex Life Sciences. Patients treated [...]

  • Live Forever report part two: Dr Halland Chen

    This month Agetech World is running a special 'Live Forever' series focusing on the future. What does healthy lifespan look like, and how long can it last? In part two we hear from Dr Halland Chen, a double board-certified Physician specialising in longevity medicine, cellular health, and biotech innovation. In an interview with Agetech World [...]